Orgabio Holdings Berhad (KLSE:ORGABIO)
Malaysia · Delayed Price · Currency is MYR 0.3150
0.00 (0.00%)
At close: Jul 29, 2025
Revance Therapeutics Market Cap
Orgabio Holdings Berhad has a market cap or net worth of 79.32 million as of August 1, 2025. Its market cap has decreased by -18.99% in one year.
Market Cap
79.32M
Enterprise Value
82.61M
Revenue
97.75M
Ranking
n/a
PE Ratio
18.01
Stock Price
$0.32
Market Cap Chart
Since July 5, 2022, Orgabio Holdings Berhad's market cap has decreased from 84.28M to 79.32M, a decrease of -5.88%. That is a compound annual growth rate of -1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 79.32M | -15.79% |
| Dec 31, 2024 | 94.19M | 46.15% |
| Dec 29, 2023 | 64.45M | -25.71% |
| Dec 30, 2022 | 86.75M | 2.94% |
| Jul 5, 2022 | 84.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Malayan Banking Berhad | 115.98B |
| Public Bank Berhad | 81.31B |
| Tenaga Nasional Berhad | 77.53B |
| CIMB Group Holdings Berhad | 70.45B |
| IHH Healthcare Berhad | 59.04B |
| Celcomdigi Berhad | 44.70B |
| Press Metal Aluminium Holdings Berhad | 43.92B |
| Hong Leong Bank Berhad | 39.24B |